Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1- γ-Positive Dermatomyositis
We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyositis (DM) after receiving a second dose of the AstraZeneca COVID-19 vaccine. Under treatment with prednisolone and monoclonal antibody therapy of abatacept, her skin lesions improved, and her muscle power increased. The serum creatinine phosphokinase level decreased from 4858 to 220 U/L, and the anti-TIF1-γ antibody titer decreased from 202 to 99. Flow cytometry data showed an increase in T cells, while NK cells, B cells (CD19), and plasma blasts all decreased...
Source: Medicina (Kaunas) - September 28, 2023 Category: Universities & Medical Training Authors: Chih-Feng Wu Wan-Ting Chen Yen-Lin Chen Feng-Cheng Liu Source Type: research
